Learning from cerebrospinal fluid drug-resistant HIV escape-associated encephalitis: a case report
Authors:
Open Access
- 10 December 2023
- journal article
- case report
- Published by Springer Nature in Virology Journal
- Vol. 20 (1) , 1-5
Abstract
In the era of antiretroviral therapy (ART), central nervous system (CNS) complications in patients with human immunodeficiency virus (HIV) infection are sometimes associated with cerebrospinal fluid (CSF) viral escape. Here, we reported a case of persistent CNS viral escape with recurrent symptomatic encephalitis, which had ultimate stabilization achieved by a combination of ART adjustment and corticosteroids. A 27-year-old man with HIV infection complained of recurrent headaches during the last year. His magnetic resonance imaging (MRI) presented diffused bilateral white matter lesions, and laboratory tests confirmed elevated CSF protein level, lymphocytic pleocytosis, and detectable CSF HIV RNA (774 copies/mL). Plasma HIV RNA was well suppressed with tenofovir, lamivudine, and lopinavir/ritonavir. Prednisone 60 mg once daily was initiated to reduce intracranial inflammation, followed by a good clinical response, with CSF HIV RNA still detectable (31.1 copies/mL). During the gradual tapering of prednisone, his headache relapsed, and booming viral loads were detected in both CSF (4580 copies/mL) and plasma (340 copies/mL) with consistent drug-resistant mutations. Thereupon, prednisone was resumed and the ART regimen was switched to zidovudine, lamivudine, and dolutegravir according to drug resistance tests. Persistent clinical recovery of symptoms, neuroimaging, and laboratory abnormalities were observed in the follow-up visits. CSF and plasma HIV RNA and further drug resistance tests should be monitored in HIV-infected patients with neurologic symptoms, as opportunistic infections or tumors can be ruled out. ART optimization using a sensitive regimen may be crucial for addressing CSF viral escape and the related encephalitis.Keywords
This publication has 19 references indexed in Scilit:
- Defining cerebrospinal fluid HIV RNA escapeAIDS, 2019
- Human Immunodeficiency Virus Type 1 RNA Detected in the Central Nervous System (CNS) After Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded CellsClinical Infectious Diseases, 2018
- CD8+ encephalitis: a severe but treatable HIV-related acute encephalopathyPractical Neurology, 2016
- Relapsing CD8+ encephalitis—looking for a solutionBMJ Case Reports, 2016
- HIV encephalitis related to the development of a discordant resistant virus in CNSClinical Microbiology and Infection, 2015
- Viral escape in the CNS with multidrug‐resistant HIV‐1Journal of the International AIDS Society, 2014
- Cellular Composition of Cerebrospinal Fluid in HIV-1 Infected and Uninfected SubjectsPLOS ONE, 2013
- CD8 Encephalitis in HIV-Infected Patients Receiving cART: A Treatable EntityClinical Infectious Diseases, 2013
- Cerebral CD8+ lymphocytosis in HIV-1 infected patients with immune restoration induced by HAARTActa Neuropathologica, 2004
- Independent HIV replication in paired CSF and blood viral isolates during antiretroviral therapyNeurology, 2001